# Effect of New Topical Preparation for Treatment of Acne Vulgaris

> **NCT05899699** · PHASE2 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 20 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** DAP-FLU ME
- **DRUG:** Adapalene .1% gel

## Key facts

- **NCT ID:** NCT05899699
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-05
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05899699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05899699, "Effect of New Topical Preparation for Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05899699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*